Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

180.82
BATS BZX Real-Time Price
As of 12:58pm ET
 +0.61 / +0.34%
Today’s Change
133.64
Today|||52-Week Range
184.21
+23.67%
Year-to-Date

Today’s Trading

Previous close180.21
Today’s open180.24
Day’s range178.70 - 180.95
Volume66,916
Average volume (3 months)3,632,748
Market cap$132.5B
Dividend yield2.54%
Data as of 12:58pm ET, 07/24/2017

Growth & Valuation

Earnings growth (last year)+13.02%
Earnings growth (this year)+7.18%
Earnings growth (next 5 years)+4.58%
Revenue growth (last year)+6.31%
P/E ratio17.2
Price/Sales4.86
Price/Book4.45

Competitors

 Today’s
change
Today’s
% change
GILDGilead Sciences+0.16+0.22%
BIIBBiogen+0.90+0.32%
ILMNIllumina Inc+0.55+0.32%
BIVVBioverativ Inc+0.41+0.66%
Data as of 12:59pm ET, 07/24/2017

Financials

Next reporting dateJuly 26, 2017
EPS forecast (this quarter)$3.10
Annual revenue (last year)$22.7B
Annual profit (last year)$7.7B
Net profit margin34.04%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Robert A. Bradway
Executive Vice President-
Operations
Esteban Santos
Corporate headquarters
Thousand Oaks, California

Forecasts